
æ©æ¢°åŠç¿ãçšããMASLDæ£è ã«ãããé塿§ç¡ç æç¡åŒåžã®äºæž¬ïŒå€éšæ€èšŒã䌎ã倿œèšå ±åç ç©¶
äžåœã®ç ç©¶è ãã«ããæ°ããç ç©¶ã«ãããšã8ã€ã®ç°¡äŸ¿ãªèšåºã»æ€æ»ããŒã«ãŒãããžã¹ãã£ãã¯ååž°ã¢ãã«ã«å ¥åããããšã§ãä»£è¬æ©èœé害é¢é£èèªæ§èçŸæ£ïŒMASLDïŒæ£è ãé塿§ç¡ç æç¡åŒåžïŒOSAïŒã䜵çºããŠããå¯èœæ§ã確å®ã«äºæž¬ã§ããããšãæããã«ãªã£ãããã®çºèŠã¯ãèšåºå»ãç¡ç æ€æ»ã®æ©æµãåããé«ãªã¹ã¯MASLDæ£è ãç¹å®ããã®ã«åœ¹ç«ã¡ããã¹ãŠã®æ£è ã«é«é¡ã§æéã®ãããã¹ã¯ãªãŒãã³ã°ã宿œããå¿ èŠããªããå¯èœæ§ãããã ç ç©¶çµæ BMC Endocrine Disordersã«çºè¡šããããã®å€æœèšå ±åã¬ããã¹ãã¯ãã£ãç ç©¶ã«ã¯ãäžåœã®2ã€ã®ç é¢ã®510äººã®æ£è ãå«ãŸãããéçºã³ããŒãã¯é·æ²»åžã®åå¹³ç é¢ã®310人ãå€éšæ€èšŒã³ããŒãã¯é éµåžäººæ°å»é¢ã®200äººã§æ§æããããå šæ£è ãMASLDãšç¢ºå®èšºæãããOSA蚺æã®ãŽãŒã«ãã¹ã¿ã³ããŒãã§ããããªãœã ãã°ã©ãã£ãŒãåããã ç ç©¶è ãã¯ãããžã¹ãã£ãã¯ååž°ãæ±ºå®æšãã©ã³ãã ãã©ã¬ã¹ãããµããŒããã¯ã¿ãŒãã·ã³ã人工ãã¥ãŒã©ã«ãããã¯ãŒã¯ãXGBoostãLightGBMã®7ã€ã®æ©æ¢°åŠç¿ã¢ãã«ãæ¯èŒãããããžã¹ãã£ãã¯ååž°ãæãåªããããã©ãŒãã³ã¹ã瀺ããèå¥èœïŒOSAãšéOSAã®çäŸãã©ã®çšåºŠåºå¥ã§ãããïŒãè§£éå¯èœæ§ïŒèšåºå»ãã¢ãã«ã®æšè«ãã©ã®çšåºŠå®¹æã«çè§£ã§ãããïŒãèŒæ£ïŒäºæž¬ç¢ºçãå®éã®çµæãšã©ã®çšåºŠäžèŽãããïŒãå€éšå®å®æ§ïŒã¢ãã«ãæ°ããæ£è éå£ã«ã©ã®çšåºŠäžè¬åã§ãããïŒã®éã§æã匷åãªãã©ã³ã¹ãéæããã æçµã¢ãã«ã¯ãæ§å¥ãäœæ Œææ°ïŒBMIïŒãé«è¡å§æŽã2åç³å°¿ç ïŒT2DMïŒãã¢ã©ãã³ã¢ãããã©ã³ã¹ãã§ã©ãŒãŒïŒALTïŒãγ-ã°ã«ã¿ãã«ãã©ã³ã¹ãã§ã©ãŒãŒïŒGGTïŒã奜äžçã»ãªã³ãçæ¯ïŒNLRïŒãäžæ§èèª-ã°ã«ã³ãŒã¹ïŒTyGïŒææ°ã®8ã€ã®å®¹æã«å ¥æå¯èœãªäºæž¬å åã䜿çšããããããã®å ¥åãããã¢ãã«ã¯åå¥åããããªã¹ã¯ã¹ã³ã¢ãçæãããç ç©¶è ãã¯ããããã¢ã°ã©ã ã«å€æãããããã¯ãèšåºå»ãæ£è ã®å€ãããããããŠOSAã®äºæž¬ç¢ºçãèªã¿åãããšãã§ããèŠèŠçããŒã«ã§ããããœãããŠã§ã¢ãå®è¡ããå¿ èŠã¯ãªãã éèŠæ§ MASLDïŒä»¥åã¯éã¢ã«ã³ãŒã«æ§èèªèçŸæ£ïŒNAFLDïŒãšããŠç¥ãããŠããïŒã¯ãäžçäžã®æäººã®çŽ4人ã«1人ã眹æ£ããŠãããè¥æºãã€ã³ã¹ãªã³æµææ§ãã¡ã¿ããªãã¯ã·ã³ãããŒã ãšå¯æ¥ã«é¢é£ããŠãããç¡ç äžã®äžæ°éã®å埩çãªèè±ãç¹åŸŽãšããé塿§ç¡ç æç¡åŒåžãããã®éå£ã§ã¯éåžžã«äžè¬çã§ãããç ç©¶ã«ãããšãMASLDæ£è ã®40ïœ70ïŒ ã蚺æãããŠããªãOSAãæããŠããã äž¡çŸæ£ã®é¢é£æ§ã¯ãå ±éã®å±éºå åãè¶ ããæ·±ããã®ã§ãããäž¡çŸæ£ã¯ãéè€ãã代è¬ã»ççã¡ã«ããºã ã«ãã£ãŠåŒãèµ·ãããããOSAãç¹åŸŽã¥ããå埩çãªè¡äžé žçŽ äœäžã§ãã鿬 çäœé žçŽ ã¯ãé žåã¹ãã¬ã¹ãšå šèº«æ§ççãåŒãèµ·ãããMASLDæ£è ã®èç·ç¶çãå éãããå¯èœæ§ããããéã«ãMASLDã®ççç°å¢ã¯ãæ°éç·åŒµãšäžæ¢æ§åŒåžå¶åŸ¡ãžã®åœ±é¿ãéããŠãç¡ç æåŒåžéå®³ãæªåãããå¯èœæ§ããããäžæ¹ã®çŸæ£ãæ²»çããã°ä»æ¹ãæ¹åããå¯èœæ§ãããããäž¡æ¹ã蚺æãããŠããå Žåã«éãããã ãã®åæ¹åã®é¢ä¿ã«ãããããããOSAã¯MASLDæ£è ã«ãããŠèããéå°èšºæãããŠãããããªãœã ãã°ã©ãã£ãŒã¯é«äŸ¡ã§äžäŸ¿ã§ãããç¡ç ã»ã³ã¿ãŒã§ã¯å©çšã§ããªãããšãå€ããã©ã®æ£è ãç¡ç æ€æ»ãå¿ èŠãšããããç¹å®ã§ããèšåºäºæž¬ããŒã«ã¯ã蚺æãå¹çåããå»çè²»ãåæžããå€§èŠæš¡ã§å¢å ããŠããæ£è éå£ã®è»¢åž°ãæ¹åããå¯èœæ§ãããã ãã®ç ç©¶çµæã¯ãäºæž¬å åã«ãããé¡èãªãã¿ãŒã³ãæµ®ã圫ãã«ããŠããã奜äžçã»ãªã³ãçæ¯ãTyGææ°ïŒã€ã³ã¹ãªã³æµææ§ã®ä»£çææšïŒãªã©ã®ççããŒã«ãŒã匷åãªäºæž¬å åã§ããããšã蚌æãããMASLDãšOSAãçµã³ã€ããä»£è¬æ§ççã®äžå¿ç圹å²ãè£ä»ããŠãããããã¯ãäºæž¬ã¢ãã«ãåãªãçµ±èšçé©åã§ã¯ãªããå®éã®ç æ ççãåæ ããŠããããšã瀺åããŠããã éç ãã®ç ç©¶ã«ã¯éèŠãªéçããããã¬ããã¹ãã¯ãã£ããã¶ã€ã³ã§ãããããéžæãã€ã¢ã¹ã枬å®ãããŠããªã亀絡å åãæé€ã§ããªããå šæ£è ãäžåœã®2ã€ã®ç é¢ããã®ãã®ã§ãããä»ã®æ°æã°ã«ãŒããå»çç°å¢ã«ãããã¢ãã«ã®æ§èœã¯äžæã§ãããç ç©¶éå£ã¯äž»ã«äžå¹Žã§éäœéã§ãã£ããããããè¥å¹Žãç©èº«ããŸãã¯å€æ§ãªMASLDæ£è ãžã®äžè¬åå¯èœæ§ã¯äžç¢ºãã§ããã ç ç©¶è ãã¯ãä»åŸã®ç ç©¶ã§ã¯ãããå€§èŠæš¡ã§å€æ§ãªã³ããŒãã§ã¢ãã«ãååãã«ãã¹ãããççæ§ãµã€ãã«ã€ã³ãããªãœã ãã°ã©ãã£ãŒç±æ¥å€æ°ãªã©ã®ãã€ãªããŒã«ãŒã远å ããããšã§ç²ŸåºŠãããã«åäžãããããšãæ€èšãã¹ãã ãšææããŠãããé£ç掻ãã¿ãŒã³ãéºäŒçèæ¯ãå»çã·ã¹ãã ãç°ãªã西æŽäººéå£ã§ã®å€éšæ€èšŒã¯ç¹ã«äŸ¡å€ãããã ããã ãŸãšã MASLDæ£è ã管çããèšåºå»ã«ãšã£ãŠããã®ç ç©¶ã¯ã³ã¹ããè€éããå¢ãããšãªãOSAãªã¹ã¯ãè©äŸ¡ããå®çšçã§ããŒã¿é§ååã®æ¹æ³ãæäŸããã8ã€ã®äºæž¬å åã¯ãã¹ãŠæ¥åžžçãªèšåºã±ã¢ã®äžéšã§ãããæ§å¥ãBMIãè¡å§ã¯æ¯åã®èšºå¯ã§åéããããALTãGGTãç©ºè ¹æè¡ç³ïŒTyGææ°ã®èšç®ã«äœ¿çšïŒã¯æšæºçãªèšåºæ€æ»ã§ããã奜äžçã»ãªã³ãçæ¯ã¯ãã»ãŒæ®éçã«å®æœãããå šè¡çèšç®ããåŸããããã«ãŒãã«å°å·ããããé»åã«ã«ãã«è¡šç€ºãããããããã¢ã°ã©ã ã¯ãèšåºå»ã«1å以å ã§OSA確çã®åççãªæšå®å€ãæäŸããããšãã§ããã æ£è ã«ãšã£ãŠã®æèšãåæ§ã«çŽæ¥çã§ãããMASLDãæãããã®ã¢ãã«ã§ææãããå±éºå åãç¹ã«è¥æºãé«è¡å§ãç³å°¿ç ã®ãããããæããå Žåãç¡ç è©äŸ¡ã«ã€ããŠå»åž«ãšçžè«ãã䟡å€ããããããããªããæªæ²»çã®OSAã¯ç¡ç ã劚ããã ãã§ã¯ãªããèèã®ççãæªåãããç·ç¶çãå éããå¿è¡ç®¡ãªã¹ã¯ãé«ãããæ©æçºèŠã¯äž¡æ¹ã®çŸæ£ã®ç®¡çãå€ããã ç ç©¶è ã«ãšã£ãŠããã®ç ç©¶ã¯æ©æ¢°åŠç¿ãæçšã§ããããã«è€éã§ããå¿ èŠã¯ãªããšãã蚌æ ã®å¢å ã«å ãããã®ã§ããããã®çŽæ¥æ¯èŒã§ã¯ãæãåçŽãªã¢ãã«ããã¥ãŒã©ã«ãããã¯ãŒã¯ãåŸé ããŒã¹ãã£ã³ã°ã¢ã³ãµã³ãã«ãäžåããåæã«èšåºå»ãçè§£ããŠä¿¡é Œã§ããã»ã©éææ§ãä¿ã£ãŠãããã·ã³ãã«ããšããã©ãŒãã³ã¹ã®ãã®çµã¿åããããããèšåºå°å ¥ã«æ±ãããããã®ã§ããã Source Gao Q, et al. Machine learning-assisted prediction of obstructive sleep apnea in patients with metabolic dysfunction-associated steatotic liver disease: a multicenter study with external validation. BMC Endocrine Disorders. 2026. DOI: 10.1186/s12902-026-02391-y. PMID: 42399746. é å èš³










